Senior Leadership at the UT Southwestern Simmons Cancer Center is comprised of the Director, Deputy Director, three Associate Directors representing basic, clinical and population research and the Associate Director for Administration. These leaders are responsible for collaborations across the scientific programs of the Center, direction and strategic planning, oversight of shared resources, education, and development of community outreach and budgetary oversight. Over the past four years. Dr. James Willson has provided vision and strong leadership as Director of UT Southwestern Simmons Cancer Center. Dr. Joan Schiller was appointed Deputy Director in 2006 and has led the development of the Center's disease oriented teams and an enabling clinical research infrastructure that has been integrated with the Medical Center's affiliated hospitals. Dr. Michael White serves as Associate Director for Basic Research and in this role has been instrumental in the development of the Center's basic research programs and the engagement of UT Southwestern cancer researchers into the Cancer Center. Dr. David Euhus serves as Associate Director for Clinical Research and in this role he is responsible for developing and maintaining a robust clinical trials enterprise for the Cancer Center and in partnership with the Deputy Director has responsibility for the oversight of the clinical trials support resources and the protocol review and monitoring system. Dr. Celette Sugg Skinner, who joined the Simmons Cancer Center in 2007, serves as Associate Director for Population Science. In this role she is leading the development of a research program in population science and cancer control and building interactions between basic and clinical faculty across the cancer control spectrum. This leadership team functions as a cohesive group that together has catalyzed new transdisciplinary collaborations and coordination that are transforming the cancer research environment at UT Southwestern.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
United States
Zip Code
Eskiocak, Banu; McMillan, Elizabeth A; Mendiratta, Saurabh et al. (2017) Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov 7:832-851
Rutkowski, Joseph M; Pastor, Johanne; Sun, Kai et al. (2017) Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression. Kidney Int 91:324-337
Singh, Jaspal; Rustagi, Vineeta; Zhang, Shanrong et al. (2017) On-bead combinatorial synthesis and imaging of europium(III)-based paraCEST agents aids in identification of chemical features that enhance CEST sensitivity. Magn Reson Chem 55:747-753
Singh, Dinesh K; Kollipara, Rahul K; Vemireddy, Vamsidara et al. (2017) Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. Cell Rep 18:961-976
Gu, Yi-Feng; Cohn, Shannon; Christie, Alana et al. (2017) Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade. Cancer Discov 7:900-917
Lee, Ming Y; Sumpter Jr, Rhea; Zou, Zhongju et al. (2017) Peroxisomal protein PEX13 functions in selective autophagy. EMBO Rep 18:48-60
Gao, Boning; Huang, Chunxian; Kernstine, Kemp et al. (2017) Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions. Oncotarget 8:11114-11126
Howard, James J; Sturge, Carolyn R; Moustafa, Dina A et al. (2017) Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers. Antimicrob Agents Chemother 61:
Skinner, Celette Sugg; Ahn, Chul; Halm, Ethan A et al. (2017) Recommendation of colorectal cancer testing among primary care patients younger than 50 with elevated risk. Prev Med 102:20-23
Garcia, Sandra; Bisen, Ajit; Yan, Jingsheng et al. (2017) Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity. J Thorac Oncol 12:1489-1495

Showing the most recent 10 out of 441 publications